Auroora Group (AUROORA) investor relations material

Executive summary

• Net sales for H1 2026 rose 41.5% year-over-year to 126.3 MEUR, with organic growth at 21.0% and Q2 organic growth at 25.7%.

• Adjusted EBITA for H1 increased 118.2% to 8.2 MEUR (6.5% margin), and Q2 adjusted EBITA more than doubled to 6.5 MEUR (8.7% margin).

• Record order backlog reached 169.6 MEUR at quarter-end, providing strong visibility into 2027.

• Two acquisitions: Rasmix (January) and Teknohaus (signed June, completed August), both contributed to growth.

• IPO on Nasdaq Helsinki in April raised 40.3 MEUR, strengthening the balance sheet and acquisition capacity.

Financial highlights

• Q2 2026 net sales: 75.0 MEUR, up 41.3% year-over-year.

• Q2 2026 adjusted EBITA: 6.5 MEUR, up 144.2% year-over-year.

• H1 2026 adjusted EBITA: 8.2 MEUR, up 118.2% year-over-year.

• Cash flow from operations in H1: 7.6 MEUR; Q2 operating cash flow: 5.9 MEUR.

• Interest-bearing net debt decreased to 18.8 MEUR; equity ratio improved to 52.1%.

Outlook and guidance

• Order backlog at 169.6 MEUR provides visibility for the rest of 2026 and into 2027.

• Strategic targets for 2028: net sales 400 MEUR, adjusted EBITA margin >10%, ROCE >15%, net debt/EBITDA ≤2.0x.

• Organic growth expected to remain faster than the market, with at least half of growth from acquisitions.

• No separate financial guidance for 2026 was provided.

• Segment diversity and current resources support progress toward 2028 targets.